Nicholas Blevins’ Post

📕 [SMART READS & TIPS] for the weekend! 🔹The future of European competitiveness / Mario Draghi (European Commission) On European competitiveness and the challenges and opportunities of the pharmaceutical sector, highlighting the need for a robust regulatory framework to drive #innovation, ensure access to #medicines, and enhance the EU's independence in pharmaceutical production. 🔹Beyond Borders: EY Biotechnology Report 2024 (EY) The sector expects an increase in investment as interest rates drop. Despite reduced revenue and funding challenges, sustained growth is anticipated, driven by strategic deals and demand for technologically advanced assets. 🔹MedTech Europe's Facts & Figures 2024 (MedTech Europe) The report highlights the growth of the #medtech sector in Europe, with over 37,000 companies, mostly SMEs. It also emphasizes the positive impact on employment and technological innovation. All readings 👇 https://lnkd.in/dmHUNJMF

Baker McKenzie partner, Ben McLaughlin's opinion piece has been published in today's The Australian regarding corporate activity within the pharmaceutical and biotech corporate sectors witnessing notable shifts in 2023, setting the stage for dynamic trends and challenges in 2024. Ben unpacks how Australia will be largely influenced by events in the US. Read the full article here - https://lnkd.in/ewpYrb7q #pharma #healthcare #biotech #trends #australia #unitedstates

Baker McKenzie partner, Ben McLaughlin's opinion piece has been published in today's The Australian regarding corporate activity within the pharmaceutical and biotech corporate sectors witnessing notable shifts in 2023, setting the stage for dynamic trends and challenges in 2024. Ben unpacks how Australia will be largely influenced by events in the US. Read the full article here - https://lnkd.in/gyYr-Pq9 #pharma #healthcare #biotech #trends #australia #unitedstates

📺 Ausbiz Interview This week, LTR Pharma Executive Chairman, Lee Rodne, spoke with ausbiz journalist Juliette Saly to discuss Company's progress towards the commercialisation of its rapid treatment for Erectile Dysfunction (ED), SPONTAN®. The conversation highlighted the significance of the Company's pivotal bioequivalence study, which commenced recruitment last month. An excerpt: “We're really close to commercialising …we're going through a key registration study now, called pivotal bioequivalence study. Basically, that data is designed to help us go through the regulatory agencies - the FDA and TGA - but should also give us data to show that we are disrupting the global Viagra marketplace.” Take a look 👉 https://lnkd.in/gjB5SQnt $LTP #innovation #pharma #biotech #erectiledysfunction #menshealth

Biosimilars LatAm - Europe 2024 Online Forum: Meet the Chairman Thomas Kirchlechner! Watch his video invitation and join us for this exciting event! This unique forum will bring together leading experts from Latin America and Europe to discuss the opportunities and challenges in the #biosimilars market. Key Highlights: - COFEPRIS's new Regulatory Certainty Strategy for Mexico. - Strategies from Latin American regulatory authorities to enhance collaboration with European manufacturers. - Brazil's successful model for Partnerships for Productive Development. - Institutional initiatives for biologics production in Colombia. 📅 Dates: June 19th, 20th, and 21st 🕒 Time: Mornings in Latin America and Afternoons in Europe 📍 Format: Online Advance your knowledge and engage with industry leaders! Register now and be part of this pivotal discussion! https://lnkd.in/gizVMKtb 💰 Request your exclusive discount code now and secure your spot at this unmissable forum Organized by JackLeckerman #BiosimilarsLatAm #Europe2024 #Pharmaceuticals #LatinAmerica #Europe #HealthcareInnovation #Biotech

The #EuropeanUnion is undergoing a major overhaul of its pharmaceutical regulations, aiming to increase #drugaccess, foster #innovation, and address challenges like supply chain resilience and healthcare costs. For industry professionals, this reform could reshape how drugs are approved, priced, and distributed across member states. An important topic addressed during the panel “EU pharma reform: what to expect.” at the "𝐌𝐞𝐫𝐠𝐢𝐧𝐠 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞, 𝐋𝐚𝐰 & 𝐈𝐓 𝐟𝐨𝐫 𝐇𝐮𝐦𝐚𝐧𝐢𝐭𝐲" conference between Paola Sangiovanni Ioanna Michalopoulou and Dena Nikolaidis from Novartis Hellas, Jenny Papadonikolaki from ΣΦΕΕ / SFEE - Σύνδεσμος Φαρμακευτικών Επιχειρήσεων Ελλάδος, Katerina Patavou, Claudia Lützeler, Francisco Aranega and An Vijverman. #EUPharmaReform #NovartisHellas #ReimaginingMedicineTogether

Draft Guidance for Industry: Essential Drug Delivery Outputs for Devices Intended to Deliver Drugs and Biological Products IS OUT! SCI is excited to announce our team’s latest endeavor, a comprehensive white paper on the FDA Draft Guidance: Essential Drug Delivery Outputs for Devices Intended to Deliver Drugs and Biological Products – COMING SOON! This pivotal document delves into the intricacies of industry standards and offers insightful guidance for the development of combination products in line with the latest draft guidance. Stay tuned for its release and discover the cutting-edge strategies for incorporating this into your development programs. Keep checking our LinkedIn page, or sign up for our emails [https://lnkd.in/gA4ngeWi], for quick insights on the Draft Guidance leading up to the release of our white paper on Sutton Creek’s thoughts and application of its contents. Link to Draft Guidance: https://lnkd.in/eE_GW3Fz #CombinationProducts, #EDDO, #EPR #DrugDelivery #FDA #pharma #biotech #medtech #drugdelivery #drugdeliverydevice

With tender processes growing more competitive and complex, pharma companies need a sharp strategy to stay ahead. As the pharma industry faces increasingly competitive and complex tender processes, staying ahead requires a strategic approach. Join our upcoming Better Market Access webinar to uncover how tender excellence can unlock new value, expand market reach, and secure your competitive edge. skp.link/70we #BetterMarketAccess #Pharma #Biotech #TenderExcellence #SimonKucher

With tender processes growing more competitive and complex, pharma companies need a sharp strategy to stay ahead. As the pharma industry faces increasingly competitive and complex tender processes, staying ahead requires a strategic approach. Join our upcoming Better Market Access webinar to uncover how tender excellence can unlock new value, expand market reach, and secure your competitive edge. skp.link/70we #BetterMarketAccess #Pharma #Biotech #TenderExcellence #SimonKucher

With tender processes growing more competitive and complex, pharma companies need a sharp strategy to stay ahead. As the pharma industry faces increasingly competitive and complex tender processes, staying ahead requires a strategic approach. Join our upcoming Better Market Access webinar to uncover how tender excellence can unlock new value, expand market reach, and secure your competitive edge. skp.link/70we #BetterMarketAccess #Pharma #Biotech #TenderExcellence #SimonKucher